AbbVie Retained Earnings decreased by 15.4% to -$17.87B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 87.6%, from -$9.53B to -$17.87B. Over 5 years (FY 2020 to FY 2025), Retained Earnings shows a downward trend with a 71.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase signals strong historical profitability and reinvestment, while a decrease may indicate losses or significant dividend payouts.
This represents the cumulative net income earned by the company since its inception, minus any dividends paid to shareho...
A key metric for all established companies; growth rates are compared against peers to gauge long-term success.
retained_earnings| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $740.00M | $1.60B | $3.13B | $5.10B | $3.52B | $4.95B | $4.78B | $2.39B | $1.79B | $933.00M | -$1.00B | -$2.38B | -$3.77B | -$4.96B | -$7.90B | -$9.53B | -$11.50B | -$14.23B | -$15.49B | -$17.87B |
| QoQ Change | — | +116.2% | +95.4% | +63.2% | -31.1% | +40.9% | -3.4% | -50.0% | -25.2% | -47.8% | -207.2% | -138.4% | -58.1% | -31.7% | -59.1% | -20.6% | -20.7% | -23.7% | -8.8% | -15.4% |
| YoY Change | — | — | — | — | +375.1% | +209.6% | +53.0% | -53.1% | -49.1% | -81.2% | -120.9% | -199.6% | -310.6% | -632.0% | -690.0% | -299.6% | -205.3% | -186.7% | -96.1% | -87.6% |